Bayer’s hemophilia therapy ‘Kogenate’ voluntarily returned in Korea

Bayer Korea will voluntarily collect back its hemophilia A therapy, Kogenate FS Inj.

It will be a follow-up action to prevent a quality issue since the company encountered disapproval of its products manufactured in foreign countries on qualification.

The company has not found any problem imported in Korea, but the government explained the company decided to collect back the products in Korea...